Fabienne D Simonis1, Laura R A Schouten2, Olaf L Cremer3, David S Y Ong3,4, Gabriele Amoruso5, Gilda Cinella5, Marcus J Schultz2,6,7,8, Lieuwe D Bos2,9. 1. Department of Intensive Care, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. f.d.simonis@gmail.com. 2. Department of Intensive Care, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands. 3. Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. 4. Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands. 5. Department of Anesthesia and Intensive Care, University of Foggia, Foggia, Italy. 6. Laboratory of Experimental Intensive Care & Anesthesiology (L·E·I·C·A), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands. 7. Mahidol-Oxford Tropical Medicine Research Unit (MORU), Mahidol University, Bangkok, Thailand. 8. Nuffield Department of Medicine, University of Oxford, Oxford, UK. 9. Department of Pulmonology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Outcome prediction in patients with acute respiratory distress syndrome (ARDS) greatly improves when patients are reclassified based on predefined arterial oxygen partial pressure to fractional inspired oxygen ratios (PaO2/FiO2) and positive end-expiratory pressure (PEEP) cutoffs 24 h after the initial ARDS diagnosis. The aim of this study was to test whether outcome prediction improves when patients are reclassified based on predefined PaO2/FiO2 and PEEP cutoffs 24 h after development of mild hypoxemia while not having ARDS. METHODS: Post hoc analysis of a large prospective, multicenter, observational study that ran in the ICUs of two academic hospitals in the Netherlands between January 2011 and December 2013. Patients were classified into four groups using predefined cutoffs for PaO2/FiO2 (250 mmHg) and PEEP (5 cm H2O), both at onset of hypoxemia and after 24 h: PaO2/FiO2 ≥ 250 mmHg and PEEP < 6 cm H2O (group I), PaO2/FiO2 ≥ 250 mmHg and PEEP ≥ 6 cm H2O (group II), PaO2/FiO2 < 250 mmHg and PEEP < 6 cm H2O (group III), and PaO2/FiO2 < 250 mmHg and PEEP ≥ 6 cm H2O (group IV), to look for trend association with all-cause in-hospital mortality, the primary outcome. Secondary outcome were ICU- and 90-day mortality, and the number of ventilator-free days or ICU-free days and alive at day 28. RESULTS: The analysis included 689 consecutive patients. All-cause in-hospital mortality was 35%. There was minimal variation in mortality between the four groups at onset of hypoxemia (33, 36, 38, and 34% in groups I to IV, respectively; P = 0.65). Reclassification after 24 h resulted in a strong trend with increasing mortality from group I to group IV (31, 31, 37, and 48% in groups I to IV, respectively; P < 0.01). Similar trends were found for the secondary endpoints. CONCLUSIONS: Reclassification using PaO2/FiO2 and PEEP cutoffs after 24 h improved classification for outcome in invasively ventilated ICU patients with hypoxemia not explained by ARDS, compared to classification at onset of hypoxemia. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01905033. Registered on July 11, 2013. Retrospectively registered.
BACKGROUND: Outcome prediction in patients with acute respiratory distress syndrome (ARDS) greatly improves when patients are reclassified based on predefined arterial oxygen partial pressure to fractional inspired oxygen ratios (PaO2/FiO2) and positive end-expiratory pressure (PEEP) cutoffs 24 h after the initial ARDS diagnosis. The aim of this study was to test whether outcome prediction improves when patients are reclassified based on predefined PaO2/FiO2 and PEEP cutoffs 24 h after development of mild hypoxemia while not having ARDS. METHODS: Post hoc analysis of a large prospective, multicenter, observational study that ran in the ICUs of two academic hospitals in the Netherlands between January 2011 and December 2013. Patients were classified into four groups using predefined cutoffs for PaO2/FiO2 (250 mmHg) and PEEP (5 cm H2O), both at onset of hypoxemia and after 24 h: PaO2/FiO2 ≥ 250 mmHg and PEEP < 6 cm H2O (group I), PaO2/FiO2 ≥ 250 mmHg and PEEP ≥ 6 cm H2O (group II), PaO2/FiO2 < 250 mmHg and PEEP < 6 cm H2O (group III), and PaO2/FiO2 < 250 mmHg and PEEP ≥ 6 cm H2O (group IV), to look for trend association with all-cause in-hospital mortality, the primary outcome. Secondary outcome were ICU- and 90-day mortality, and the number of ventilator-free days or ICU-free days and alive at day 28. RESULTS: The analysis included 689 consecutive patients. All-cause in-hospital mortality was 35%. There was minimal variation in mortality between the four groups at onset of hypoxemia (33, 36, 38, and 34% in groups I to IV, respectively; P = 0.65). Reclassification after 24 h resulted in a strong trend with increasing mortality from group I to group IV (31, 31, 37, and 48% in groups I to IV, respectively; P < 0.01). Similar trends were found for the secondary endpoints. CONCLUSIONS: Reclassification using PaO2/FiO2 and PEEP cutoffs after 24 h improved classification for outcome in invasively ventilated ICU patients with hypoxemia not explained by ARDS, compared to classification at onset of hypoxemia. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01905033. Registered on July 11, 2013. Retrospectively registered.
Entities:
Keywords:
Hypoxemia; ICU-free days; Intensive care unit; Invasive ventilation; Mortality; P/F; PEEP; PaO2/FiO2; Positive end–expiratory pressure; Prognostication; Ventilator-free days
Authors: Jesús Villar; Rosa L Fernández; Alfonso Ambrós; Laura Parra; Jesús Blanco; Ana M Domínguez-Berrot; José M Gutiérrez; Lluís Blanch; José M Añón; Carmen Martín; Francisca Prieto; Javier Collado; Lina Pérez-Méndez; Robert M Kacmarek Journal: Crit Care Med Date: 2015-02 Impact factor: 7.598
Authors: Giacomo Bellani; John G Laffey; Tài Pham; Eddy Fan; Laurent Brochard; Andres Esteban; Luciano Gattinoni; Frank van Haren; Anders Larsson; Daniel F McAuley; Marco Ranieri; Gordon Rubenfeld; B Taylor Thompson; Hermann Wrigge; Arthur S Slutsky; Antonio Pesenti Journal: JAMA Date: 2016-02-23 Impact factor: 56.272
Authors: Lieuwe D Bos; Olaf L Cremer; David S Y Ong; Eliana B Caser; Carmen S V Barbas; Jesus Villar; Robert M Kacmarek; Marcus J Schultz Journal: Intensive Care Med Date: 2015-07-23 Impact factor: 17.440
Authors: Fabiana Madotto; Tài Pham; Giacomo Bellani; Lieuwe D Bos; Fabienne D Simonis; Eddy Fan; Antonio Artigas; Laurent Brochard; Marcus J Schultz; John G Laffey Journal: Intensive Care Med Date: 2018-04-09 Impact factor: 17.440
Authors: Robinder G Khemani; Sarah Rubin; Sanjay Belani; Dennis Leung; Simon Erickson; Lincoln S Smith; Jerry J Zimmerman; Christopher J L Newth Journal: Intensive Care Med Date: 2014-09-18 Impact factor: 17.440
Authors: A Vieillard-Baron; M Matthay; J L Teboul; T Bein; M Schultz; S Magder; J J Marini Journal: Intensive Care Med Date: 2016-04-01 Impact factor: 17.440
Authors: Rogier M Determann; Annick Royakkers; Esther K Wolthuis; Alexander P Vlaar; Goda Choi; Frederique Paulus; Jorrit-Jan Hofstra; Mart J de Graaff; Johanna C Korevaar; Marcus J Schultz Journal: Crit Care Date: 2010-01-07 Impact factor: 9.097
Authors: Jesús Villar; Juan M Mora-Ordoñez; Juan A Soler; Fernando Mosteiro; Anxela Vidal; Alfonso Ambrós; Lorena Fernández; Isabel Murcia; Belén Civantos; Miguel A Romera; Adrián Mira; Francisco J Díaz-Domínguez; Dácil Parrilla; J Francisco Martínez-Carmona; Domingo Martínez; Lidia Pita-García; Denis Robaglia; Ana Bueno-González; Jesús Sánchez-Ballesteros; Ángel E Pereyra; Mónica Hernández; Carlos Chamorro-Jambrina; Pilar Cobeta; Raúl I González-Luengo; Raquel Montiel; Leonor Nogales; M Mar Fernández; Blanca Arocas; Álvaro Valverde-Montoro; Ana M Del Saz-Ortiz; Victoria Olea-Jiménez; José M Añón; Pedro Rodríguez-Suárez; Rosa L Fernández; Cristina Fernández; Tamas Szakmany; Jesús M González-Martín; Carlos Ferrando; Robert M Kacmarek; Arthur S Slutsky Journal: Crit Care Explor Date: 2022-04-29